Pharmaceutical Product Development (Nasdaq:PPDI) hit a new 52-week high Wednesday as it changed hands at $30.79 compared with its previous 52-week high of $30.36. Pharmaceutical Product Development is ...

Shares of Pharmaceutical Product Development (Nasdaq:PPDI) were gapping up Monday morning with an open price 14.2% higher than Friday's closing price. The stock closed at $27.86 yesterday and opened ...

RegeneRx and Lee’s Pharmaceutical (HK) Complete License Agreement for Development of RegeneRx Product Candidates in China (including Hong Kong and Macau) and Taiwan (“the Company” or “RegeneRx”) today ...

Aurobindo's wholly owned subsidiary, Aurobindo Pharma USA, has entered into a collaboration and license agreement with an unnamed global pharma company for the development and commercialization of ...

Former pharmaceutical industry executives with a unique combination of experience in large, mid-sized, and small pharmaceutical and biotechnology companies announce today the launch of BioEndpoint ...

The global contract research organization will invest $63.7 million to expand its bioanalytical lab in Henrico County, VA. Pharmaceutical Product Development, LLC (PPD), a global contract research ...

Halo Pharma will become a stand-alone business as a result of the sale of the Noramco API and associated business to Siegfried. WHIPPANY, N.J., Jan. 27, 2026 (GLOBE NEWSWIRE) -- Halo Pharma, a leading ...

ADDoPT (Advanced Digital Design of Pharmaceutical Therapeutics) is a major U.K.-led supply chain project established in response to the challenges currently faced by the pharmaceuticals and healthcare ...

For breakthrough product development, Pharmaceutical Quality System (PQS) requirements need to be followed while supplying suitable flexibility to suit accelerated activities for breakthrough product ...